Papenburg, J., Defoy, I., Massé, E., Caouette, G., & Lebel, M. H. (2020). Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study. J Pediatric Infect Dis Soc.

Papenburg, Jesse, Isabelle Defoy, Edith Massé, Georges Caouette, και Marc H. Lebel. "Impact of the Withdrawal of Palivizumab Immunoprophylaxis On the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born At 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study." J Pediatric Infect Dis Soc 2020.

Papenburg, Jesse, et al. "Impact of the Withdrawal of Palivizumab Immunoprophylaxis On the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born At 33 to 35 Weeks’ Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study." J Pediatric Infect Dis Soc 2020.